Historical record - last NADAC effective date: 3/20/2019
Product Information
CETIRIZINE HCL 10 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.0784 per EA under NDC 00781168401. Its NADAC has been published 279 times since Nov 28, 2013.
FDA first approved this application on Dec 27, 2007.
The High Outlier badge above means this manufacturer's average price in the Cetirizine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Sandoz Inc.NDC
00781168401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/20/2019
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077946FDA Approved
12/27/2007
On Market Since
12/27/2007
Pharmacological Classes
Price Statistics
The NADAC for CETIRIZINE HCL 10 MG TABLET has been published 279 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0784 per EA |
|---|---|
| All-time high | $0.0985 (Feb 12, 2014) |
| All-time low | $0.0636 (Mar 22, 2017) |
| Median price | $0.0805 |
| Average price | $0.0797 |
| Largest weekly change | +28.3% (Jun 17, 2015) |
| Weeks tracked | 279 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-1.0%
Last surveyed Mar 27, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 16 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cetirizine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CETIRIZINE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CETIRIZINE HCL 10 MG TABLET, manufactured by Sandoz Inc., is $0.0784 per EA (NDC 00781168401), effective Mar 27, 2019.
How has the price of CETIRIZINE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CETIRIZINE HCL 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 279 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CETIRIZINE HCL 10 MG TABLET?
Since Nov 28, 2013, the NADAC for CETIRIZINE HCL 10 MG TABLET has ranged from a low of $0.0636 (Mar 22, 2017) to a high of $0.0985 (Feb 12, 2014), with a median of $0.0805 per EA.
Are there cheaper alternatives to CETIRIZINE HCL 10 MG TABLET?
Yes. 16 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALL DAY ALLERGY 10 MG TABLET, is $0.0613 per EA — about 22% below CETIRIZINE HCL 10 MG TABLET.
Who manufactures CETIRIZINE HCL 10 MG TABLET?
CETIRIZINE HCL 10 MG TABLET (NDC 00781168401) is labeled by Sandoz Inc., and CMS classifies it as a generic product.